Obure Carol Dayo, Sweeney Sedona, Darsamo Vanessa, Michaels-Igbokwe Christine, Guinness Lorna, Terris-Prestholt Fern, Muketo Esther, Nhlabatsi Zelda, Warren Charlotte E, Mayhew Susannah, Watts Charlotte, Vassall Anna
Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Family Health Options Kenya, Nairobi, Kenya.
PLoS One. 2015 May 1;10(5):e0124476. doi: 10.1371/journal.pone.0124476. eCollection 2015.
To present evidence on the total costs and unit costs of delivering six integrated sexual reproductive health and HIV services in a high and medium HIV prevalence setting, in order to support policy makers and planners scaling up these essential services.
A retrospective facility based costing study conducted in 40 non-government organization and public health facilities in Kenya and Swaziland.
Economic and financial costs were collected retrospectively for the year 2010/11, from each study site with an aim to estimate the cost per visit of six integrated HIV and SRH services. A full cost analysis using a combination of bottom-up and step-down costing methods was conducted from the health provider's perspective. The main unit of analysis is the economic unit cost per visit for each service. Costs are converted to 2013 International dollars.
The mean cost per visit for the HIV/SRH services ranged from $Int 14.23 (PNC visit) to $Int 74.21 (HIV treatment visit). We found considerable variation in the unit costs per visit across settings with family planning services exhibiting the least variation ($Int 6.71-52.24) and STI treatment and HIV treatment visits exhibiting the highest variation in unit cost ranging from ($Int 5.44-281.85) and ($Int 0.83-314.95), respectively. Unit costs of visits were driven by fixed costs while variability in visit costs across facilities was explained mainly by technology used and service maturity.
For all services, variability in unit costs and cost components suggest that potential exists to reduce costs through better use of both human and capital resources, despite the high proportion of expenditure on drugs and medical supplies. Further work is required to explore the key drivers of efficiency and interventions that may facilitate efficiency improvements.
提供在艾滋病毒高流行率和中等流行率环境中提供六项综合性性与生殖健康及艾滋病毒服务的总成本和单位成本的证据,以支持政策制定者和规划者扩大这些基本服务。
在肯尼亚和斯威士兰的40个非政府组织及公共卫生机构开展的一项基于机构成本核算的回顾性研究。
回顾性收集2010/11年度各研究地点的经济成本和财务成本,旨在估算六项综合性艾滋病毒与性和生殖健康服务的每次就诊成本。从卫生服务提供者的角度,采用自下而上和逐步递减成本核算方法相结合的方式进行全面成本分析。主要分析单位是每项服务的每次就诊经济单位成本。成本换算为2013年国际美元。
艾滋病毒/性与生殖健康服务的每次就诊平均成本从14.23国际美元(围产保健就诊)到74.21国际美元(艾滋病毒治疗就诊)不等。我们发现,不同环境下每次就诊的单位成本存在很大差异,计划生育服务的差异最小(6.71 - 52.24国际美元),性传播感染治疗和艾滋病毒治疗就诊的单位成本差异最大,分别为5.44 - 281.85国际美元和0.83 - 314.95国际美元。就诊单位成本由固定成本驱动,而各机构就诊成本的差异主要由所使用的技术和服务成熟度来解释。
对于所有服务而言,单位成本和成本构成的差异表明,尽管药品和医疗用品支出占比很高,但仍有可能通过更好地利用人力和资本资源来降低成本。需要进一步开展工作,以探索效率的关键驱动因素以及可能促进效率提高的干预措施。